NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Medico Remedies Limited (NSE: MEDICO)
MEDICO Technical Analysis
3
As on 2nd Apr 2025 MEDICO SHARE Price closed @ 54.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 69.75 & Sell for SHORT-TERM with Stoploss of 62.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MEDICOSHARE Price
Open | 53.00 | Change | Price | % |
High | 54.77 | 1 Day | 0.70 | 1.31 |
Low | 51.61 | 1 Week | 9.12 | 20.32 |
Close | 54.00 | 1 Month | -2.75 | -4.85 |
Volume | 438334 | 1 Year | 3.70 | 7.36 |
52 Week High 387.00 | 52 Week Low 44.64 |
NSE INDIA Most Active Stocks
IDEA | 8.22 | 1.48% |
YESBANK | 17.40 | 0.40% |
CENTRALBK | 36.86 | -10.77% |
IDFCFIRSTB | 57.19 | 0.03% |
ZOMATO | 212.03 | 4.96% |
BEL | 282.40 | -3.29% |
SUZLON | 57.43 | 3.01% |
GTLINFRA | 1.48 | -1.33% |
UCOBANK | 30.04 | -3.72% |
KALYANKJIL | 511.10 | 11.58% |
NSE INDIA Top Gainers Stocks
HESTERBIO | 1786.70 | 20.00% |
KEYFINSERV | 339.20 | 18.52% |
BROOKS | 129.18 | 16.64% |
KANANIIND | 2.27 | 14.65% |
GUJALKALI | 647.75 | 14.50% |
VALIANTORG | 335.90 | 13.61% |
DUCON | 5.85 | 13.15% |
DBREALTY | 171.16 | 11.78% |
KALYANKJIL | 511.10 | 11.58% |
VMART | 3290.35 | 11.42% |
NSE INDIA Top Losers Stocks
MEDICO Daily Charts |
MEDICO Intraday Charts |
Whats New @ Bazaartrend |
MEDICO Free Analysis |
|
MEDICO Important Levels Intraday
RESISTANCE | 60.09 |
RESISTANCE | 58.14 |
RESISTANCE | 56.93 |
RESISTANCE | 55.72 |
SUPPORT | 52.28 |
SUPPORT | 51.07 |
SUPPORT | 49.86 |
SUPPORT | 47.91 |
MEDICO Target April 2025
4th UP Target | 113.94 |
3rd UP Target | 95.6 |
2nd UP Target | 84.26 |
1st UP Target | 72.93 |
1st DOWN Target | 40.57 |
2nd DOWN Target | 29.24 |
3rd DOWN Target | 17.9 |
4th DOWN Target | -0.44 |
MEDICO Weekly Target
4th UP Target | 74.25 |
3rd UP Target | 66.98 |
2nd UP Target | 62.48 |
1st UP Target | 57.98 |
1st DOWN Target | 45.16 |
2nd DOWN Target | 40.66 |
3rd DOWN Target | 36.16 |
4th DOWN Target | 28.89 |
MEDICO Target2025
4th UP Target | 150.57 |
3rd UP Target | 119.9 |
2nd UP Target | 100.95 |
1st UP Target | 81.99 |
1st DOWN Target | 27.91 |
2nd DOWN Target | 8.95 |
3rd DOWN Target | -10 |
4th DOWN Target | -40.67 |
Medico Remedies Limited ( NSE INDIA Symbol : MEDICO )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
MEDICO Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
MEDICO Other Details
Segment | BE | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
MEDICO Address
![]() |
MEDICO Latest News
MEDICO Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service